Harper University Hospital

Detroit, Michigan 48201-2018

1 studies enrolling now · 34 studies all time

What they study most

Acute Kidney Injury, Bacterial Diseases, CMV, COVID-19, Candidemia, Candidiasis, Catheter-Related Infections, Chest Pain, Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Occlusion

Studies at this site

• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
• Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis — Completed
• Absorb IV Randomized Controlled Trial — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants — Completed
• An Algorithmic Approach to Ventilator Withdrawal at the End of Life — Completed
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients — Completed
• A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis — Completed
• Convalescent Plasma in Outpatients With COVID-19 — Completed
• HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma — Status unconfirmed
• A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients — Completed
• Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients — Completed
• Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial — Completed
• Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure — Completed
• CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension — Completed
• Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI — Available (expanded access)
• A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
• Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis — Completed
• Deceased Donor Biomarkers and Recipient Outcomes — Completed
• A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F) — Completed
• Preclinical Detection of Sepsis Early in Hospitalized Patients Following Surgery, Injury or Severe Illness — Status unconfirmed
• EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients — Completed
• The Chimerix CMX001 Registry — Stopped early
• Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence — Status unconfirmed
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF — Completed
• Caspofungin Study for Fungal Infections in Adults in Critical Care Settings — Stopped early
• Advanced Cardiovascular Imaging Consortium — Completed
• MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis — Completed
• Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis — Completed
• Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial — Completed